Authors

Gerald F Watts

DSc, PhD, MD, FRACP, FRCP, Winthrop Professor and Consultant Physician, Medical School, University of Western Australia, Perth, WA; Head, Lipid Disorders Clinic, Cardiometabolic Service, Departments of Cardiology and Internal Medicine, Royal Perth Hospital, Perth, WA


Awareness of familial hypercholesterolaemia in Australian primary care: A qualitative descriptive study

Despite recent exponential growth in research on familial hypercholesterolaemia, there remains a general lack of public and health professional awareness about the disorder.


Cost impact of undertaking detection and management of familial hypercholesterolaemia in Australian general practice

Screening and management in general practice has the potential for substantial health benefits while requiring relatively modest investments from the health system.


Evolving worldwide approaches to lipid management and implications for Australian general practice

Guidelines on assessing and managing lipid disorders are evolving as new knowledge and treatments emerge to help health professionals and patients decide the best course of disease management.


Familial hypercholesterolaemia and cascade testing in general practice: Lessons from COVID-19

The recent increased public experience with epidemiological concepts such as contact tracing offers new potential to improve detection and management of familial hypercholesterolaemia.


Participant experiences of intervention to detect and manage familial hypercholesterolaemia in Australian general practice: A qualitative descriptive study

Patient health literacy is a barrier to both management of familial hypercholesterolaemia and cascade testing.


Implications of new clinical practice guidance on familial hypercholesterolaemia for Australian general practitioners

Recent consensus advice on the care of patients with familial hypercholesterolaemia (FH) supports improved care of patients with FH in the primary care setting.